2018 Speakers

Speakers

Peter Atadja
Executive Director, Drug Discovery
NOVARTIS
Ping-Chung Chang
Head, Biostatistics & Programming Operation Asia
PPD
JIanwen Chen
Vice President, Medical Development
JIANGSU HENGRUI MEDICINE
PJ Chen
VP, Head of Clinical & Medical Affairs Center & President
UNITED BIOPHARMA CHINA
Julie Cong
Senior Associate Director, Statistics
BOEHRINGER-INGELHEIM
Alex Forrest
Head of Life Sciences
CHUBB
Daotian Fu
Vice President & Managing Director
LIVZON PHARMACEUTICAL GROUP
Tong Guo
VP, Business Development, Greater China
IQVIA
Yongjiang Hei
Chief Medical Officer, Oncology
ZAI LAB
Jennifer Hou
Director, Phase I Clinical Center
PKUCARE LUZHONG HOSPITAL
Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS
Min Irwin
Chief Executive Officer
REISTONE BIOPHARMA
Helen Jiang
Senior Vice President & Chief Medical Officer
QINGFENG MEDICINE
Yue Kang
China Development Director
ABBVIE
Minnie Ke
Country Medical Head
SHIRE
Luana Pesco Koplowitz
President & Chief Medical & Scientific Officer
DUCK FLATS PHARMA
Howe Li
Founder, Chairman & Chief Executive Officer
DELTAMED
Jin Li
Professor and Chair, Department of Oncology
SHANGHAI EASTERN HOSPITAL
Xuening Li
Director of of Medical Institution Conducting Clinical Trials for Human Used Drug
HUASHAN HOSPITAL OF FUDAN UNIVERSITY
Yong Li
Chief Physician, Cardiology
HUASHAN HOSPITAL OF FUDAN UNIVERSITY
Cece Liu
Life Science Specialist, Underwriting Manager of Industry Practices
CHUBB APAC
Scott Liu
President & Chief Executive Officer
SHANGHAI HENLIUS BIOTECH
Xiaoni Liu
Director, Biostatistics
NOVARTIS
Chris Lu
Chief Executive Officer
LAEKNA THERAPEUTICS
Paul Manley
Executive Director, Leading Scientist Oncology Research
NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH
Yimin Mao
Professor of Gastroenterology & Chief Executive Officer, State Institution for Drug Clinical Research
RENJI HOSPITAL
Jay Mei
Chief Executive Officer & Chairman
ANTENGENE CORPORATION
Bin Peng
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS
Sanjeev Redkar
Chief Executive Officer
CBT PHARMA
Joan Shen
Head of Research and Development
I-MAB BIOPHARMA
Yang Shen
Professor, Department of Hematology
RUIJIN HOSPITAL
Xiaowei Shi
Executive Director, Clinical Operations
BEIGENE
Gloria Wang
Chief Medical Officer
TASLY BIOPHARMA
Heidi Wang
Vice President, Head of Global Regulatory Sciences China & Hong Kong
BRISTOL-MYERS SQUIBB
Jerry Wang
Head of Global Biostatistics, Epidemiology, and Medical Writing, China
MERCK SERONO
Jingsong Wang
Founder, Chairman & Chief Executive Officer
HARBOUR BIOMED
Jonathan Wang
Senior Managing Director
ORBIMED
Lin Wang
Head of Takeda Development Center; Asia Vice President, Global Medical Science & Development Operation, R&D
TAKEDA
Susan Wang
Head of Biostatistics and Data Sciences Asia
BOEHRINGER-INGELHEIM
Michael Winlo
Chief Executive Officer
LINEAR CLINICAL RESEARCH
Yan Wu
Vice President, Head of Clinical Operation and Immunology Development
HUTCHISON MEDIPHARMA
Jason Yang
Chief Medical Officer, Senior Vice President, Clinical Development
CSTONE PHARMACEUTICALS
Sophia Yang
Senior Director of Clinical Research Operations
JW THERAPEUTICS
Anny Yin
Senior Director, Biostatistics
CSTONE PHARMA
Helen Yu
Executive Medical Director, Drug Safety
IONIS PHARMACEUTICALS
Yong Yue
Chief Medical Officer
LAEKNA THERAPEUTICS
Carrie Zhang
Chief Executive Officer
ECLINWISE, PANACEA TECHNOLOGY
Dan Zhang
Executive Chairman
FOUNTAIN MEDICAL DEVELOPMENT
Jing Zhang
Director, Ministry Key Laboratory on Clinical Antibiotic Pharmacology / Director, Phase I Clinical Trial Unit;Vice Director, Institute of Antibiotics; Executive Deputy Director, Clinical Trials Institue
NATIONAL HEALTH AND FAMILY PLANNING COMMISSION / HUASHAN HOSPITAL
Lianshan Zhang
Senior Vice President and Global R&D President
JIANGSU HENGRUI MEDICINE
Mark Zhang
Partner
KING & WOOD MALLESONS
Bitao Zhao
Chief Operation Officer
ESTART MEDICAL
Sean Zhao
Head of US Patient Safety Surveillance, US Medical Affairs
ASTRAZENECA
Zhenping Zhu
Chief Scientific Officer & President of R&D
3SBIO